Authorship and contributorship

This policy ensures that contributors who have made substantive intellectual contributions to an article are given credit and that contributors understand their role in taking responsibility and being accountable for what is published. Contributors are either author contributors (meaning that they meet all four authorship criteria – see below) or non-author contributors.

BMJ credits and lists contributors in two ways:

    • Authorship – we publish a list of authors’ names at the beginning of the paper in the byline
    • Contributorship – we publish a contributorship statement at the end of the paper, giving details of who did what in planning, conducting, and reporting the work. This should include all author contributors and may include non-author contributors.

We also publish an acknowledgements statement at the end of the paper, detailing those who helped in carrying out the research but that have not been recognised as contributors, and for personal expressions of gratitude.

 
Authorship

The International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations 2019) recommend that authorship be based on the following four criteria:

        1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
        2. Drafting the work or revising it critically for important intellectual content; AND
        3. Final approval of the version to be published; AND
        4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

BMJ requires that all those designated as authors should meet all four ICMJE criteria for authorship, and all who meet the four criteria should be identified as author contributors. We recognise only natural persons (an individual human being, as opposed to a private or public organisation) as authors. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria should not be used to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion number 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting and final approval of the manuscript.

Contributors who have contributed materially to the paper but whose contributions do not justify authorship should be described clearly in the contributorship statement.

In addition to being accountable for the parts of the work they have done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

Submitting authors should provide assurance that all authors included on a paper fulfil the criteria of authorship. We also ask for assurance that there is no one else who fulfils the criteria that has been excluded as an author.

When we encounter disagreements among authors we follow guidance from the Committee on Publication Ethics (COPE).

Submitting author

The submitting author takes primary responsibility for submitting the article to the journal using our manuscript submission system ScholarOne and for communicating with the journal during the article submission, peer review and revision process. They ensure that all of the journal’s administrative requirements are properly completed. These include, but are not limited to, providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements. These tasks may be delegated to one or more co-authors, but the submitting author remains responsible for them.

When you submit your article through our submission system you will be asked to provide a name, email address and institutional affiliation for all author contributors. In the final published article author names, institutions and addresses will be taken from these completed fields and not from the submitted Word document.

Affiliations listed should be those where the work was carried out at the time the research/article was written. If institution details appear incorrectly these can be directly amended under ‘Actions’ by selecting the ‘Edit’ drop down next to each author.

All author contributors receive a confirmation email when an article has been submitted and when a final decision is made.

The submitting author should assign the corresponding author when providing author details (see below for more information about the corresponding author role). The submitting author and corresponding author can be the same person.

Corresponding author

The corresponding author, as listed on ScholarOne, takes primary responsibility for completing all necessary actions after acceptance of the manuscript and communicating with the journal and with readers after publication. All email communication from BMJ will be sent to the corresponding author including:

        • The timeline for your article proof with a link to Publishing at Work where you can track your article’s status
        • If your article will be published open access or in colour in the print edition of the journal, you will receive an email from Rightslink with payment options and instructions. If you are not making the payment yourself, you may forward the email to the person or organisation that will be paying on your behalf
        • A link to review and approve the proof when available
        • Confirmation that your article has been published online
        • Notifications when a response has been posted to your article

Find out more about what to expect when your article has been accepted.

Although we include only one corresponding author on ScholarOne for email communication, multiple authors can be listed with correspondence information in the author byline of the final published article. This information can be included at the article proof stage, after acceptance.

Note, the policy for The BMJ differs and can be found here

 
Joint first authorship

Joint first authors can be indicated by the inclusion of the statement ‘X and X contributed equally to this paper’ in the contributorship statement.

 
Collaborators (group authorship)

Collaborators are a large group of multi-author contributors (e.g. a specific consortium, committee, study group or the like). Collaborators should decide who will be an author before the work is started and confirm who is an author before submitting the manuscript for publication. All members of the group named as authors should meet all four criteria for authorship as detailed above. They will also be expected as individuals to complete conflict-of-interest disclosure forms and provide a summary in the relevant section.

The collaborator group name(s) should be included in the main author list on ScholarOne. The collaborator group name(s) followed by the individual names should also be listed in the ‘Collaborator’ field on ScholarOne. BMJ will list the author group name(s) in the author byline, with the full list of individual names included in a collaborator statement at the end of the article. Details of the group’s contributions should also be listed in the ‘Contributorship statement’ field on ScholarOne.

If the journal is indexed in PubMed (MEDLINE and/or PubMed Central), the group name will be listed in the author byline and the names of individual group members entered as collaborators on the PubMed record to ensure individual due credit.

Examples:

The BMJ
Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries

PubMed record >>

BMJ Open
Establishing a core outcome set for treatment of uncomplicated appendicitis in children: study protocol for an international Delphi survey

PubMed record >>

AI authors

AI technologies will not be accepted as an author(s) of any content submitted to BMJ for publication. BMJ only recognises humans as being capable of authorship since they must be accountable for the work.

 
Deceased authors

It can be a challenge when an individual has died during the course of the work, to judge whether they should be an author. For example, a challenge can be that they cannot approve the final version, or complete other duties which are associated with authorship. We support a pragmatic approach which seeks to honour individuals who would have been likely to be authors, were it not for their death. We also encourage credit to be given to those who have contributed to work (but whose contribution does not amount to authorship). Authorship is typically decided by the authors. However, BMJ may need to balance the interests of all involved. For example, the deceased author’s rights (copyright and moral rights) form part of their estate and means that BMJ asks that individuals contact the next of kin in circumstances where an author has died prior to publication of the work. We do not support gift or ghost authorship of deceased individuals; the individual must have directly contributed to the work.

In judging whether a deceased individual should be an author, BMJ suggests that authors consider:

  • If the individual had not died, do the remaining authors consider it very likely that the deceased individual would have been included as an author? 

  • What would the likely wishes of the deceased individual be with respect to authorship? 

  • What do the next of kin/individuals with power of attorney judge that the deceased individual would have wanted? 

  • Are there any aspects of the final work with which the deceased individual might have felt uncomfortable or that they might have communicated differently?

Describing the contribution of deceased individuals

  • Reporting in the contributorship statement: Describe which author/s are deceased and the aspects of the work which the deceased individual/s contributed to. Please also note any key aspects to which the deceased author could not contribute. Tributes to the deceased individual should be restricted to brief comments such as a dedication to the person’s memory, or thanks; lengthy tributes are unsuitable in the contributorship statement.

  • Authorship responsibilities: The deceased author cannot be the submitting author, corresponding author, or the work’s guarantor, at the time of publication. If necessary, these roles should be reallocated among the living authors. 

  • Declarations and conflicts of interest: If the individual were unable to declare their interests, the remaining authors should report interests on behalf of the deceased individual, to the best of their knowledge. Authors should endeavour to consult with the next of kin to capture as many interests as are relevant.

Circumstances in which an author in a prominent authorship role has died after publication

In the event that an individual has died after the publication of the work, BMJ does not typically amend details of the corresponding author or guarantor. If in the view of the authors there is a need to update details for correspondence, a rapid response to your content outlining who should be contacted is likely to suffice.

Incapacity

This policy does not cover circumstances in which an author is temporarily or permanently lacking capacity. These circumstances will be considered on a case by case basis.

 
Alteration to authorship

If an author’s affiliation has changed during the course of the work, the author may either list the affiliation at the time that the research (or most significant portion of the research) was conducted, or their current affiliation, or both. The change of affiliation can be explained in an acknowledgements section.

Any change in authors after initial submission and before publication must be approved by all authors. This applies to additions, deletions, a change of order to the authors’ names or a change to the attribution of contributions. Any alterations must be explained to the Editor. The Editor may contact any of the authors and/or contributors to ascertain whether they have agreed to any alteration.

 
Contributorship statement

A contributorship statement is required for every article submitted and should outline who has contributed what to the planning, conduct and reporting of the work described in the article. A contributorship statement should include author contributors, non author contributors and group author contributors (collaborators). Contributors who have contributed materially to the paper but whose contributions do not justify authorship should be described clearly in the contributorship statement; for example, “served as scientific advisors”, “critically reviewed the study proposal”, “collected data” or “provided and cared for study patients”.

Researchers must determine among themselves the precise nature of each person’s contribution, and we encourage open discussion among all participants to reach a consensus.

This is also the appropriate place to include contributions by patients or members of the public who have assisted as research volunteers, giving their names and specific roles. We encourage authors to fully acknowledge the contribution of patients and the public to their research where appropriate.

All individuals named in the contributorship statement must give permission to be included, as readers may infer their endorsement of the data and conclusions of the paper. It is the responsibility of the submitting author to ensure that permission is obtained and to be able to provide evidence of this if required.

Each contributorship statement must make clear who is responsible for the overall content as guarantor. The guarantor accepts full responsibility for the finished work and/or the conduct of the study, had access to the data, and controlled the decision to publish.

AI use
  1. To ensure transparent declaration of AI, authors should:
  • 1. Include an acknowledgement of AI use in the ‘contributor’ section of written material. If the AI use was in the course of research, a fuller description should be included in the methods section.2. Transparent declaration includes a description of:
      • What AI technology was used (the name of the technology)
      • Why this AI technology was used (the reason for its use)
      • How the AI technology was used (what the task of the technology was)
      • Consider including a summary of the input, output, and the way in which the AI output was reviewed on the part of the authors as supplementary files or additional information for the editor to review. The editor may ask for more information and/or for information to be added to the content for internal use and/or for publication.

     
    Acknowledgements

    An acknowledgements statement may be included at the end of the paper, detailing those who helped in carrying out the research but who have not been recognised as contributors, as well as for personal expressions of gratitude.

    Because acknowledgment may imply endorsement by acknowledged individuals of a study’s data and conclusions, authors are strongly advised to obtain permission to be acknowledged from all acknowledged individuals before submitting to any BMJ journal.

     

    Author name change requests

    As an inclusive publisher, BMJ wishes to ensure a smooth process and experience to facilitate author name changes after publication. For more information on how to request an author name change in an existing publication see our corrections policies.

    Last updated: March 2023